Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction of thrombin with human platelets.

P Ganguly

    British Journal of Haematology
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Researchers identified thrombosthenin as a key platelet receptor for thrombin. Blocking these thrombosthenin sites potentiates platelet aggregation, revealing a novel mechanism in blood clotting.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Regulation of Angiogenesis Discriminates Tissue Resident MSCs from Effective and Defective Osteogenic Environments.

    Journal of clinical medicine·2020
    Same author

    An evaluation of immunization services, using the reaching every district criteria, in two districts of Gujarat, India.

    Global health research and policy·2018
    Same author

    Inherited Factor X (Stuart-Prower Factor) deficiency and its management.

    Medical journal, Armed Forces India·2015
    Same author

    Unsuspected pheochromocytoma multisystem crisis: a fatal outcome in a young male patient.

    The Journal of the Association of Physicians of India·2013
    Same author

    A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.

    The pharmacogenomics journal·2012
    Same author

    Technique for measuring grating frequency.

    Applied optics·2010
    Same journal

    Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

    British journal of haematology·2026
    Same journal

    Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes.

    British journal of haematology·2026
    Same journal

    Author response to Zhang and Chen.

    British journal of haematology·2026
    Same journal

    Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

    British journal of haematology·2026
    Same journal

    Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

    British journal of haematology·2026
    Same journal

    Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

    British journal of haematology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Biochemistry
    • Molecular Biology

    Background:

    • Platelet aggregation is initiated by thrombin binding to specific platelet membrane receptors.
    • Understanding the identity of these thrombin receptors is crucial for elucidating platelet activation pathways.

    Purpose of the Study:

    • To identify and characterize the thrombin receptor on human platelets.
    • To investigate the role of thrombosthenin as a potential thrombin receptor.

    Main Methods:

    • Utilized radioactively labeled thrombin for binding studies.
    • Employed disc gel electrophoresis and Sephadex G-200 gel filtration for protein isolation and characterization.
    • Performed immunoprecipitation with specific antisera and SDS-PAGE for molecular analysis.
    • Investigated the effect of thrombosthenin antibodies on platelet aggregation.

    Related Experiment Videos

    Main Results:

    • A single radioactive peak was isolated from thrombin-treated platelets, co-eluting with thrombosthenin.
    • The isolated protein exhibited characteristics of thrombosthenin and reacted specifically with anti-thrombosthenin antiserum.
    • Complexing thrombosthenin receptor sites with antibodies potentiated, rather than inhibited, platelet aggregation.

    Conclusions:

    • Thrombosthenin is identified as a likely receptor for thrombin on human platelets.
    • Blocking thrombosthenin sites is essential for sensitizing platelets to aggregation.
    • This finding offers new insights into the regulation of platelet activation and thrombin signaling.